|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,241 JPY | +0.21% |
|
+0.93% | +4.61% |
| 12:44pm | Takeda Pharmaceutical Prices Second Hybrid Bonds for 460 Billion Yen | MT |
| Jun. 06 | Former Takeda Employee Pleads Guilty to Defrauding Company | DJ |
Oct 14 (Reuters) - Advisors to the European Medicines Agency (EMA) on Friday backed the use of a tetravalent dengue vaccine by the German unit of Japan's Takeda for people aged four years and above. (Reporting by Raghav Mahobe; Editing by Maju Samuel)
| 1st Jan change | Capi. | |
|---|---|---|
| +4.61% | 42.4B | |
| +45.82% | 765B | |
| -6.16% | 354B | |
| +19.86% | 331B | |
| +9.32% | 299B | |
| +18.87% | 248B | |
| -1.72% | 219B | |
| +11.09% | 216B | |
| +5.90% | 164B | |
| -0.73% | 162B |
TAKEDA PHARMACEUTICAL COMPANY LIMITED 
